Seqens Seqens

X

Find Radio Compass News for Gaboxadol

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

https://www.biospace.com/article/healx-and-ovid-therapeutics-enter-partnership-for-fragile-x-therapy/

H. Shasteen BIOSPACE
09 Feb 2022

http://www.pharmafile.com/news/565290/ovids-angelman-syndrome-therapy-falls-short-phase-3

PHARMAFILE
02 Dec 2020

https://investors.ovidrx.com/news-releases/news-release-details/ovid-therapeutics-present-american-epilepsy-society-aes-2020

PRESSRELEASE
23 Nov 2020

https://www.fiercebiotech.com/biotech/angelini-lands-eu-rights-to-ovid-s-phase-3-rare-disease-drug

Nick P Taylor FIERCE BIOTECH
14 Jul 2020

https://investors.ovidrx.com/news-releases/news-release-details/ovid-therapeutics-announces-positive-topline-results-phase-2

PRESS RELEASE
08 May 2020
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY